CVS Health Corp.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CVS Health Corp.
VC funding will remain challenging for many in the health care industry, Silicon Valley Bank’s market manager Milo Bissin told attendees at the recent DHIS West conference. Companies focusing on promising areas such as AI-powered technologies, women’s health and value-based care likely have the best chances to draw investors’ attention.
Blue Shield Of California’s Pharmacy Benefit Overhaul Could Still See Boost From Transparency Legislation
The payor’s multiyear plan to ditch the traditional PBM model and use multiple vendors has drawn a lot of skepticism from other actors in the health care system, but Blue Shield is hoping that it can help give policymakers some momentum, VP Lum tells the Pink Sheet.
Ranking Republican on Senate HELP Committee seeks detailed information on companies’ 340B operations, revenue sources and whether discounts are shared with patients.
CVS Health’s new subsidiary Cordavis will help manufacturers produce and/or commercialize biosimilars with the aim of reducing overall drug costs while improving access to and affordability of medicines.
- OTC, Consumer
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.